Citations - Rob Lukas

CONCLUSIONS: Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.... Read more
Published on: 2020-08-22
Source: Rob Lukas
By: Michal Hensler
CONCLUSIONS: Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.... Read more
Published on: 2020-08-22
Source: Rob Lukas
By: Michal Hensler
CONCLUSIONS: Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.... Read more
Published on: 2020-08-22
Source: Rob Lukas
By: Michal Hensler
CONCLUSIONS: Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.... Read more
Published on: 2020-08-22
Source: Rob Lukas
By: Michal Hensler
CONCLUSIONS: Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.... Read more
Published on: 2020-08-22
Source: Rob Lukas
By: Michal Hensler
CONCLUSIONS: Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.... Read more
Published on: 2020-08-22
Source: Rob Lukas
By: Michal Hensler

Other Resources

Other Citations

Other Citations

News by Specialization

News by Specialization

Videos

Selection of Videos by Specialization

Latest News

Latest News

Translate »